Skip to main content
. 2017 Jul 6;102(6):1299–1312. doi: 10.1189/jlb.2HI0317-088RR

Figure 1. Prophylactic CRF1 antagonism attenuates IgE-mediated PSA in vivo.

Figure 1.

C57B6 WT, male mice (6–8 wk old), sensitized overnight with IgE (20 µg in 100 µl PBS), were administered PBS (vehicle) or the CRF1 antagonist antalarmin (15 mg/kg, i.v.) 30 min before i.p. injection of DNP-HSA to induce PSA. (A) Serum histamine levels in mice 120 min after PSA induction. (B) Change in body temperature after induction of PSA. (C) Average number of degranulated MCs per ×20 field in intestinal mesentery among treatment groups. (D) Representative images of mesenteric MCs stained with toluidine blue (TB) from each treatment group. Arrows indicate TB-stained MCs. Data represent means ± se and were analyzed using a 1-way ANOVA with a post hoc Tukey’s test. *#P < 0.05 vs. other treatment groups.